Not a member? Sign up for free!

The Evolving Psychopharmacology Of Major Depressive Disorder: Narrowing The Treatment Gap

Webinar | July 23, 2015 12:00 pm to 1:00 pm
You must be logged in to register for PsychU events.

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU

Description

Virtual Forum: The Evolving Psychopharmacology Of Major Depressive Disorder: Narrowing The Treatment Gap

Location: Online Via PsychU.org

Description: Depression is a widespread condition estimated to affect millions of adults in the United States alone. Despite the significant burden associated with depression, only a fraction of patients are estimated to receive minimally adequate treatment. While there are a number of treatment options and guidelines for treatment strategies exist, depression continues to constitute a significant source of burden. There are several theories regarding the underlying pathology of depression which have implicated structural and functional changes in the brain and alterations in neurotransmitter signaling. The psychopharmacology of current treatment options differ, however their effects may be optimized by targeting multiple systems in treating depression.
During this virtual forum, Rakesh Jain, MD, MPH, Clinical Professor in the Department of Psychiatry at Texas Tech Health Sciences Center Medical School in Midland, Texas and Vladimir Maletic, MD, MS, Clinical Professor of Neuropsychiatry and Behavioral Science at the University of South Carolina School of Medicine in Columbia and Consulting Associate in the Division of Child and Adolescent Psychiatry at the Duke University Medical Center in Durham, North Carolina will discuss the current thinking regarding the psychopharmacology underlying Major Depressive Disorder. The virtual forum will cover an overview of the imbalance of neurotransmitter systems that have been implicated in depression and a discussion of the potential need to target multiple systems during treatment. The speakers will discuss considerations for the potential impact of depression and inadequate treatment response on brain structure and function, and will also provide an overview of the psychopharmacology of current treatment options and the role of augmentation in treatment of depression. The presentation will conclude with time for questions from the audience.
Drs. Jain and Maletic are paid consultants for Otsuka America Pharmaceutical, Inc.

Event Speakers

Rakesh Jain, MD, MPH
Featured Speaker

Clinical Professor in the Department of Psychiatry at Texas Tech Health Sciences Center Medical School at Permian Basin in Midland, TX

Vladimir Maletic, MD, MS
Featured Speaker

Clinical Professor of Neuropsychiatry and Behavioral Science at the University of South Carolina School of Medicine in Columbia, SC and Consulting Associate in the Division of Child and Adolescent Psychiatry at Duke University Medical Center in Durham, NC

You must be logged in to register for PsychU events.

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU